agilon health, inc. (AGL)
NYSE: AGL · Real-Time Price · USD
1.970
+0.090 (4.79%)
Dec 20, 2024, 4:00 PM EST - Market closed
agilon health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Operating Revenue | 5,582 | 4,307 | 2,385 | 1,518 | 1,214 | 788.57 |
| Other Revenue | 12.11 | 9.01 | 3.33 | 3.17 | 4.06 | 5.85 |
| Revenue | 5,594 | 4,316 | 2,388 | 1,521 | 1,218 | 794.41 |
| Revenue Growth (YoY) | 54.10% | 80.74% | 56.97% | 24.88% | 53.36% | - |
| Cost of Revenue | 5,646 | 4,247 | 2,277 | 1,456 | 1,124 | 765.9 |
| Gross Profit | -51.77 | 69.67 | 111.36 | 65.74 | 94.15 | 28.51 |
| Selling, General & Admin | 269.31 | 285.76 | 205.79 | 422.1 | 137.29 | 122.83 |
| Operating Expenses | 292.01 | 301.8 | 214.74 | 432.59 | 150.82 | 135.09 |
| Operating Income | -343.78 | -232.13 | -103.38 | -366.84 | -56.67 | -106.57 |
| Interest Expense | -6.6 | -6.66 | -4.48 | -6.15 | -8.14 | -9.07 |
| Interest & Investment Income | 21.44 | 27.84 | 13.93 | - | - | - |
| Earnings From Equity Investments | 9.67 | 16.49 | 10.72 | -6.77 | 0.51 | -0.75 |
| Other Non Operating Income (Expenses) | 12.79 | - | - | 2.18 | 1.95 | 1.7 |
| EBT Excluding Unusual Items | -306.48 | -194.46 | -83.21 | -377.58 | -62.34 | -114.69 |
| Other Unusual Items | -4.55 | - | -7.46 | -5.4 | - | - |
| Pretax Income | -311.03 | -194.46 | -90.67 | -382.98 | -62.34 | -114.69 |
| Income Tax Expense | -0.04 | 0.79 | 1.64 | 0.89 | 0.87 | -0.23 |
| Earnings From Continuing Operations | -310.99 | -195.25 | -92.31 | -383.86 | -63.21 | -114.46 |
| Earnings From Discontinued Operations | -73.81 | -67.55 | -14.55 | -22.93 | 3.16 | -168.29 |
| Net Income to Company | -384.8 | -262.8 | -106.86 | -406.79 | -60.05 | -282.74 |
| Minority Interest in Earnings | 0 | 0.21 | 0.31 | 0.3 | - | 0.15 |
| Net Income | -384.79 | -262.6 | -106.55 | -406.49 | -60.05 | -282.59 |
| Net Income to Common | -384.79 | -262.6 | -106.55 | -406.49 | -60.05 | -282.59 |
| Shares Outstanding (Basic) | 408 | 409 | 408 | 373 | 323 | 295 |
| Shares Outstanding (Diluted) | 408 | 409 | 408 | 373 | 323 | 295 |
| Shares Change (YoY) | -1.04% | 0.19% | 9.44% | 15.29% | 9.75% | - |
| EPS (Basic) | -0.94 | -0.64 | -0.26 | -1.09 | -0.19 | -0.96 |
| EPS (Diluted) | -0.94 | -0.64 | -0.26 | -1.09 | -0.19 | -0.96 |
| Free Cash Flow | -149.28 | -172.03 | -146.23 | -154.72 | -54.98 | -106.75 |
| Free Cash Flow Per Share | -0.37 | -0.42 | -0.36 | -0.41 | -0.17 | -0.36 |
| Gross Margin | -0.93% | 1.61% | 4.66% | 4.32% | 7.73% | 3.59% |
| Operating Margin | -6.15% | -5.38% | -4.33% | -24.11% | -4.65% | -13.42% |
| Profit Margin | -6.88% | -6.08% | -4.46% | -26.72% | -4.93% | -35.57% |
| Free Cash Flow Margin | -2.67% | -3.99% | -6.12% | -10.17% | -4.51% | -13.44% |
| EBITDA | -321.08 | -216.09 | -94.43 | -356.36 | -43.14 | -94.32 |
| EBITDA Margin | -5.74% | -5.01% | -3.95% | -23.42% | -3.54% | -11.87% |
| D&A For EBITDA | 22.7 | 16.04 | 8.95 | 10.48 | 13.53 | 12.25 |
| EBIT | -343.78 | -232.13 | -103.38 | -366.84 | -56.67 | -106.57 |
| EBIT Margin | -6.15% | -5.38% | -4.33% | -24.11% | -4.65% | -13.42% |
| Revenue as Reported | 5,594 | 4,316 | 2,388 | 1,521 | 1,218 | 794.41 |
Source: S&P Capital IQ. Standard template. Financial Sources.